Krystal Biotech, Inc. (KRYS)

Market price: $320.58

5 valuation methods

• EV / Revenue: $88.89 to $162.65 (midpoint $116.13)
• EV / EBITDA: $106.59 to $336.72 (midpoint $149.20)
• P / E: $150.35 to $588.24 (midpoint $239.47)
• DCF (FCFF): $203.12 to $300.78 (midpoint $243.78)
• P / B: $164.66 to $564.61 (midpoint $264.70)